ID

20826

Descripción

A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT00358930

Link

https://clinicaltrials.gov/show/NCT00358930

Palabras clave

Versiones (1)
  1. 20/3/17 20/3/17 -
Subido en

20 de marzo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Head and Neck Neoplasms NCT00358930

Inglés

Eligibility Head and Neck Neoplasms NCT00358930

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. able to provide signed and dated informed consent document prior to study-specific screening procedures.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
2. histologically or cytologically confirmed locally advanced, recurrent or metastatic scchn.
Descripción

Squamous cell carcinoma of the head and neck Advanced Local | Squamous cell carcinoma of the head and neck Recurrent | Squamous cell carcinoma of the head and neck metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1168401
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205276
UMLS CUI [2,1]
C1168401
UMLS CUI [2,2]
C2945760
UMLS CUI [3,1]
C1168401
UMLS CUI [3,2]
C1522484
3. measurable disease per recist.
Descripción

Measurable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
4. ≥ 18 years old.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
5. karnofsky performance status (kps) ≥ 70%.
Descripción

Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
6. male or female patients of child-producing potential must agree to use contraception or avoidance of pregnancy measures during the study and for 30 days after the last infusion of arq 501.
Descripción

Fertility Contraceptive methods | Fertility Avoidance of pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0015895
UMLS CUI [2,2]
C1821946
7. hemoglobin (hgb) ≥ 10 g/dl.
Descripción

Hemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518015
8. absolute neutrophil count (anc) ≥ 1.5 x 10^9/l (≥ 1,500/mm³).
Descripción

Absolute neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
9. platelet count ≥ 100 x 10^9/l ( ≥ 100,000/mm³).
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
10. total bilirubin less than or equal to 1.5 x upper limit of normal (uln) or less than or equal to 3.0 x uln with metastatic liver disease.
Descripción

Serum total bilirubin measurement | Secondary malignant neoplasm of liver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0494165
11. aspartate aminotransferase (ast) and alanine aminotransferase (alt) less than or equal to 2.5 x uln or less than or equal to 5.0 x uln with metastatic liver disease.
Descripción

Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
UMLS CUI [3]
C0494165
12. creatinine less than or equal to 1.5 x uln.
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. primary tumor of nasopharyngeal origin.
Descripción

Nasopharyngeal Neoplasm Primary

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027439
UMLS CUI [1,2]
C0205225
2. eligible for curative surgery or radiotherapy.
Descripción

Curative Surgery Patient Appropriate | Therapeutic radiology procedure Patient Appropriate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1511562
UMLS CUI [1,2]
C0030705
UMLS CUI [1,3]
C1548787
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0030705
UMLS CUI [2,3]
C1548787
3. received three or more systemic anticancer regimens.
Descripción

Cancer treatment Systemic Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C1265611
4. have active, uncontrolled systemic infection considered opportunistic, life threatening or clinically significant at the time of treatment.
Descripción

Sepsis Uncontrolled Opportunistic | Sepsis Uncontrolled Life Threatening | Sepsis Uncontrolled Clinical Significance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0243026
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0029118
UMLS CUI [2,1]
C0243026
UMLS CUI [2,2]
C0205318
UMLS CUI [2,3]
C2826244
UMLS CUI [3,1]
C0243026
UMLS CUI [3,2]
C0205318
UMLS CUI [3,3]
C2826293
5. have received anticancer chemotherapy, immunotherapy, radiotherapy, or investigational agents within three weeks of first infusion.
Descripción

Chemotherapy Malignant Neoplasm | Immunotherapy Malignant Neoplasm | Therapeutic radiology procedure Malignant Neoplasm | Investigational New Drugs Malignant Neoplasm

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0006826
UMLS CUI [2,1]
C0021083
UMLS CUI [2,2]
C0006826
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0006826
UMLS CUI [4,1]
C0013230
UMLS CUI [4,2]
C0006826
6. surgery within two weeks of first infusion.
Descripción

Operative Surgical Procedures

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0543467
7. have symptomatic or untreated central nervous system (cns) involvement.
Descripción

Central Nervous System Involvement Symptomatic | Central Nervous System Involvement untreated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C4050309
UMLS CUI [2,2]
C0332155
8. are pregnant or lactating.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
9. previous exposure to arq 501.
Descripción

ARQ 501 Exposure to

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1328233
UMLS CUI [1,2]
C0332157
Volver a la parte superior de la página

Similar models

Eligibility Head and Neck Neoplasms NCT00358930

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
1. able to provide signed and dated informed consent document prior to study-specific screening procedures.
boolean
C0021430 (UMLS CUI [1])
Squamous cell carcinoma of the head and neck Advanced Local | Squamous cell carcinoma of the head and neck Recurrent | Squamous cell carcinoma of the head and neck metastatic
Item
2. histologically or cytologically confirmed locally advanced, recurrent or metastatic scchn.
boolean
C1168401 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C1168401 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C1168401 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
Measurable Disease
Item
3. measurable disease per recist.
boolean
C1513041 (UMLS CUI [1])
Age
Item
4. ≥ 18 years old.
boolean
C0001779 (UMLS CUI [1])
Karnofsky Performance Status
Item
5. karnofsky performance status (kps) ≥ 70%.
boolean
C0206065 (UMLS CUI [1])
Fertility Contraceptive methods | Fertility Avoidance of pregnancy
Item
6. male or female patients of child-producing potential must agree to use contraception or avoidance of pregnancy measures during the study and for 30 days after the last infusion of arq 501.
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0015895 (UMLS CUI [2,1])
C1821946 (UMLS CUI [2,2])
Hemoglobin measurement
Item
7. hemoglobin (hgb) ≥ 10 g/dl.
boolean
C0518015 (UMLS CUI [1])
Absolute neutrophil count
Item
8. absolute neutrophil count (anc) ≥ 1.5 x 10^9/l (≥ 1,500/mm³).
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
9. platelet count ≥ 100 x 10^9/l ( ≥ 100,000/mm³).
boolean
C0032181 (UMLS CUI [1])
Serum total bilirubin measurement | Secondary malignant neoplasm of liver
Item
10. total bilirubin less than or equal to 1.5 x upper limit of normal (uln) or less than or equal to 3.0 x uln with metastatic liver disease.
boolean
C1278039 (UMLS CUI [1])
C0494165 (UMLS CUI [2])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver
Item
11. aspartate aminotransferase (ast) and alanine aminotransferase (alt) less than or equal to 2.5 x uln or less than or equal to 5.0 x uln with metastatic liver disease.
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0494165 (UMLS CUI [3])
Creatinine measurement, serum
Item
12. creatinine less than or equal to 1.5 x uln.
boolean
C0201976 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Nasopharyngeal Neoplasm Primary
Item
1. primary tumor of nasopharyngeal origin.
boolean
C0027439 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
Curative Surgery Patient Appropriate | Therapeutic radiology procedure Patient Appropriate
Item
2. eligible for curative surgery or radiotherapy.
boolean
C1511562 (UMLS CUI [1,1])
C0030705 (UMLS CUI [1,2])
C1548787 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0030705 (UMLS CUI [2,2])
C1548787 (UMLS CUI [2,3])
Cancer treatment Systemic Quantity
Item
3. received three or more systemic anticancer regimens.
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Sepsis Uncontrolled Opportunistic | Sepsis Uncontrolled Life Threatening | Sepsis Uncontrolled Clinical Significance
Item
4. have active, uncontrolled systemic infection considered opportunistic, life threatening or clinically significant at the time of treatment.
boolean
C0243026 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0029118 (UMLS CUI [1,3])
C0243026 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C2826244 (UMLS CUI [2,3])
C0243026 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C2826293 (UMLS CUI [3,3])
Chemotherapy Malignant Neoplasm | Immunotherapy Malignant Neoplasm | Therapeutic radiology procedure Malignant Neoplasm | Investigational New Drugs Malignant Neoplasm
Item
5. have received anticancer chemotherapy, immunotherapy, radiotherapy, or investigational agents within three weeks of first infusion.
boolean
C0392920 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C0013230 (UMLS CUI [4,1])
C0006826 (UMLS CUI [4,2])
Operative Surgical Procedures
Item
6. surgery within two weeks of first infusion.
boolean
C0543467 (UMLS CUI [1])
Central Nervous System Involvement Symptomatic | Central Nervous System Involvement untreated
Item
7. have symptomatic or untreated central nervous system (cns) involvement.
boolean
C4050309 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C4050309 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
8. are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
ARQ 501 Exposure to
Item
9. previous exposure to arq 501.
boolean
C1328233 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial